جست‌وجوی استاد و پژوهشگر

J. Martin Rodriguezمشاهده پروفایل

استاد

• Infectious Diseases
• Clostridioides difficile Infections
• Phage Therapy
• +۵ مورد دیگر

J. Martin Rodriguez, MD, is a Professor of Medicine at the University of Alabama at Birmingham (UAB) School of Medicine and School of Public Health. He serves as the Physician for Adults in the UAB Undiagnosed Diseases Program and has held leadership roles, including Director of Clinical Activities since 2016. His expertise spans Infectious Diseases and Epidemiology , with a focus on Clostridioides difficile , autoinflammatory diseases , and travel-associated infections . Education: Doctor of Medicine from Universidad Peruana Cayetano Heredia (1998), Residency at UAB Hospital (2003), Fellowship in Infectious Diseases at Massachusetts General Hospital (2005). Research Interests: Dr. Rodriguez investigates antimicrobial stewardship , fecal microbiota transplantation (FMT) , diagnostic strategies for refractory infections , and medical education innovations . His work on FMT delivery methods and vancomycin AUC/MIC thresholds has significantly influenced clinical guidelines. Scientific Contributions: His 15 most recent articles (2013-2023) cover C. difficile , phage therapy , autoinflammatory diseases , and Zika virus prevention , with a focus on health economics , microbial engraftment , and gamification in education . Scientific Awards: Outstanding Teaching Award (2010–present) C. Glenn Cobbs/Edwin A. Rutsky Award for Clinical Excellence (2010–present) UAB President’s Award for Excellence in Teaching (2023) Grants: He has secured extramural funding for studies on Candidemia , antifungal resistance , CDI , and microbiome-based therapies , collaborating with institutions like Duke University, Emory University, and industry partners (Cidara Therapeutics, Seres Therapeutics). Labs & Teams: He leads the largest research program in the UAB Department of Medicine - Infectious Diseases and directs clinical services including the Travel Clinic, Infectious Diseases Clinic, and Tinsley Harrison Clinical Scholars Service.

• Infectious Diseases
• Pharmacology
• Nanomedicine
• +۳ مورد دیگر

Christopher J. Destache is a Professor in the Department of Pharmacy Practice at Creighton University School of Pharmacy and Health Professions. He holds dual roles as a faculty member and infectious diseases specialist, with a focus on HIV/AIDS, nanomedicine, and antimicrobial stewardship. His academic career began at Creighton University, where he earned his PharmD in 1984, followed by a Family Medicine Research Fellowship. He transitioned to academia in 1993, becoming tenured in 1995. Education PharmD, Creighton University (1984) Research Interests Dr. Destache’s research spans clinical infectious diseases, HIV pathogenesis, and nanotechnology applications in drug delivery. His work emphasizes nanoparticle-based therapies for HIV prevention and treatment, as well as optimizing antimicrobial stewardship programs to combat resistance. Recent Research Themes His publications highlight studies on HIV prophylaxis via nanoparticles, outcomes of patients with comorbidities during the COVID-19 pandemic, and novel antimicrobial agents against mycobacterial infections. Key contributions include the development of long-acting antiretroviral formulations and assessments of therapeutic efficacy in humanized mouse models. Grants & Awards Recipient of FCCP and BCIDP certifications. Leading antimicrobial stewardship initiatives at Creighton’s health systems, focusing on improving antibiotic use and reducing Clostridioides difficile readmissions. Teaching & Mentorship Precepts 4th-year pharmacy students in infectious diseases consultations, teaches in pharmacy and physician assistant programs, and mentors infectious diseases fellows. Active in interprofessional education and telemedicine-driven stewardship outreach to rural hospitals. Labs & Teams Based in the Department of Pharmacy Practice , collaborates with virology, nanomedicine, and clinical pharmacology teams. Involved in multi-institutional projects through the Nebraska Center for Virology and Creighton’s antimicrobial stewardship network.

Sabrina TAMBURINIمشاهده پروفایل

استادیار

• Microbiology
• Human Microbiome
• Cancer Immunotherapy
• +۳ مورد دیگر

Sabrina Tamburini is an Assistant Professor in Microbiology at the Department of Molecular Sciences and Nanosystems, Ca' Foscari University of Venice. She holds a PhD in Biomolecular Sciences from the University of Trento and postdoctoral training at the Icahn School of Medicine at Mount Sinai (NY, USA). Her academic role includes teaching microbiology courses in Master’s and Doctoral programs, as well as supervising laboratory activities in nanomaterial-based therapeutics and microbiome research. Education : PhD in Biomolecular Sciences (Microbiology), University of Trento, 2013 Master’s Degree in Molecular and Cellular Biology, University of Bologna, 2007 Bachelor’s Degree in Biological Sciences, University of Bologna, 2004 Research Focus : Tamburini’s work centers on the human microbiome’s role in health and disease. Key areas include gut microbiome dynamics during fecal microbial transplantation, microbiome reshaping in infants (e.g., C-section delivery effects), microbiome contributions to cancer therapy efficacy (e.g., immunotherapy), and aging-related microbiome changes. She develops novel viability assays for bacterial community analysis in environmental and clinical samples. Publications : Her recent studies explore coffee’s impact on gut microbiota composition, microbiome-genomic associations in melanoma treatment, and microbial communities in biliary stents. These reflect her interdisciplinary approach linking microbiology to clinical and environmental applications. Awards : 2024 Science Slam Award, Ca’ Foscari 2023 FEMS Award (SIMGBM Conference) 2018 Robin Chemers Neustein Postdoctoral Fellowship Collaborations : She collaborates with Prof. Nicola Segata (CIBIO Trento), Prof. Jose Clemente (Mount Sinai), and Prof. Roberto Rusconi (Humanitas University), focusing on computational metagenomics and translational microbiome research.

• Biostatistics
• Spatio-temporal Modeling
• Public Health Surveillance
• +۵ مورد دیگر

David M. Kline is an Associate Professor and Interim Vice Chair in the Department of Biostatistics and Data Science within the Division of Public Health Sciences at Wake Forest University School of Medicine. He holds secondary faculty appointments in the Department of Epidemiology and Prevention and is an Affiliate Faculty member in the Department of Statistical Sciences. Additionally, he is a Full Member of the Center for Addiction Research and the Maya Angelou Research Center for Healthy Communities, and co-leads the Spatial and Environmental Statistics in Health (SESH) Lab. Dr. Kline earned his BA in Mathematics from Messiah College in 2010, followed by an MS in Statistics from The Ohio State University in 2012, and completed his PhD in Biostatistics from The Ohio State University in 2015. Prior to joining Wake Forest in 2021, he served as an Assistant Professor in the Department of Biomedical Informatics and was a member of the Center for Biostatistics at The Ohio State University College of Medicine. His research focuses on developing advanced biostatistical methodologies to address challenges in public health surveillance, with particular emphasis on multivariate Bayesian hierarchical models for spatio-temporal disease mapping. Dr. Kline specializes in leveraging multiple data sources to tackle complex public health problems, most notably the opioid epidemic. His methodological expertise includes small area estimation, spatio-temporal methods, multivariate modeling, and Bayesian statistics. He actively collaborates with subject matter experts across various health disciplines to apply these methods to pressing scientific questions. Dr. Kline's recent publications demonstrate a strong focus on opioid misuse estimation, spatio-temporal modeling of disease patterns, and public health surveillance methods. His work spans multiple domains including infectious disease tracking, substance use disorders, and healthcare access analysis. The publications reveal a consistent application of sophisticated statistical techniques to address real-world public health challenges with spatial and temporal dimensions. 2024 Emerging Leader Award, Wake Forest University School of Medicine 2023 & 2022 Top 10 Research Paper, Wake Forest University School of Medicine Division of Public Health Sciences 2020 Excellence in Teaching Award, The Ohio State University Department of Biomedical Informatics 2015 CSP Best Student Poster Runner-up, American Statistical Association 2014 Lester R. Curtin Award, American Statistical Association Dr. Kline serves as Principal Investigator on multiple NIH-funded research projects, including R21DA045236 and R01DA052214 focused on spatio-temporal methods for surveillance of the opioid syndemic. He mentors several trainees, including F31 and F30 recipients. His collaborative work spans numerous interdisciplinary projects addressing health disparities, infectious disease surveillance, and substance use disorders. Currently, he serves on the Editorial Board for the journal Epidemiology, reflecting his standing in the field. As co-leader of the Spatial and Environmental Statistics in Health Lab, Dr. Kline directs research that bridges biostatistics, spatial analysis, and public health. His lab focuses on developing innovative methods for analyzing health data with spatial and temporal components, particularly for problems involving small area estimation and multi-source data integration. This work has significant implications for public health policy and practice, especially in addressing the opioid crisis and health disparities.

Mark Pattersonمشاهده پروفایل

دانشیار

• Implementation Science
• Community Pharmacy
• Health Information Technology
• +۳ مورد دیگر

Mark Patterson is Associate Professor in the Division of Pharmacy Practice and Administration at the University of Missouri-Kansas City School of Pharmacy. He holds a Ph.D. in Pharmaceutical Outcomes from University of North Carolina-Chapel Hill (2006), an MPH in Chronic Disease Epidemiology from Yale University (2002), and completed postdoctoral training at Duke Clinical Research Institute. Research focuses on implementation science applications in healthcare: Community pharmacy-based health interventions AI integration in clinical workflows Health information technology challenges Pharmacoeconomic analysis Chronic disease management models Current projects include evaluating community health worker programs in pharmacies and AI adoption in South African healthcare systems. Publications demonstrate expertise in medication safety during care transitions, pharmacoepidemiology, and health technology assessment. Teaching responsibilities include coordinating 'Economics of Health and Medicine' for pharmacy students. Professional activities include editorial board membership for Exploratory Research in Clinical and Social Pharmacy and Implementation Science Communications . No awards or supervised students are documented.

Sol Del Mar Aldreteمشاهده پروفایل

استادیار

• HIV/AIDS
• Infectious Diseases
• Antiretroviral Therapy
• +۳ مورد دیگر

Sol Del Mar Aldrete, MD is an Assistant Professor in the Department of Medicine, Division of Infectious Diseases at the Medical College of Wisconsin (MCW). She serves as an Associate Fellowship Program Director and practices at Froedtert Hospital and Vivent Health. Dr. Aldrete specializes in infectious diseases with a focus on HIV care, particularly immune non-response to antiretroviral therapies and CD4 T-cell recovery patterns. She also contributes to infectious disease consultations in both inpatient and outpatient settings. Education: MD from Universidad Panamericana (2009), Internal Medicine residency (2013), and Infectious Diseases fellowship (2016) at Emory University. Her research investigates CD4 T-cell dynamics in HIV patients, aiming to predict adverse outcomes through immune recovery metrics. She has published on HIV pathogenesis, C. difficile epidemiology, and antibiotic stewardship, reflecting her dual clinical and investigative expertise. Dr. Aldrete is board-certified in Internal Medicine and Infectious Diseases.

CHRISTOPHER M. BLANDمشاهده پروفایل

استاد

• Antimicrobial Stewardship
• Clinical Pharmacy
• Infectious Diseases
• +۵ مورد دیگر

Christopher M. Bland, Pharm.D., BCPS, FIDSA, FCCP, holds the Albert W. Jowdy Professorship in Pharmacy Care at the University of Georgia's College of Pharmacy. His expertise spans clinical pharmacy practice, antimicrobial stewardship, and healthcare education. He focuses on optimizing antibiotic use, penicillin allergy management, and improving patient outcomes through pharmacist-led interventions. Dr. Bland's research addresses critical areas such as antibiotic safety in pregnancy, microbiome impacts on infections, and challenges in electronic health record analysis for student pharmacists. He has pioneered initiatives like penicillin allergy delabeling programs and fluid stewardship strategies in critical care settings. Awards: Board Certified Pharmacotherapy Specialist (BCPS), Fellow of the Infectious Diseases Society of America (FIDSA), and Fellow of the American College of Clinical Pharmacology (FCCP). Key Contributions: Over 100 peer-reviewed publications, including influential work on antimicrobial stewardship interventions and clinical pharmacy practice innovations. Education: Leads efforts to enhance pharmacy curricula through interprofessional education and applied research electives. His work emphasizes bridging clinical practice and research, particularly in optimizing antibiotic use, minimizing resistance, and improving healthcare delivery efficiency. Recent studies highlight cost-effectiveness analyses of antibiotics and the role of pharmacists in emergency care protocols.

• Microbiology
• Immunology
• Infectious Diseases
• +۱ مورد دیگر

Claire Béliveau serves as an Associate Professor in the Department of Microbiology, Infectious Diseases and Immunology at the Faculty of Medicine, Université de Montréal. She maintains clinical affiliations with CIUSSS de l'Est-de-l'Île-de-Montréal – Hôpital Maisonneuve-Rosemont (HMR), where she conducts research on viral infections in immunocompromised populations. Doctor of Medicine (1980), Université de Montréal Fellow, Royal College of Physicians and Surgeons of Canada in Medical Microbiology (1985), Université de Montréal Advanced Virology Training (1986), Hôpital Trousseau de Paris Her research program focuses on viral pathogenesis in transplant recipients, particularly hepatitis C and cytomegalovirus infections in bone marrow transplant patients. She investigates occupational viral transmission risks in childcare settings and develops diagnostic methods for bacterial pathogens like Clostridium difficile. Her work bridges clinical virology, diagnostic microbiology, and infectious disease epidemiology with direct applications to patient care protocols. Professor Béliveau holds key educational responsibilities including restructuring the medical preparatory year curriculum, directing the Microbiology and Virology course (MMD 1010), and co-directing the Virology course (MCB 6090). She serves as a provincial HIV committee representative through CALI and provides expert consultation to SERTIH. Her laboratory work at Hôpital Maisonneuve-Rosemont integrates clinical virology with translational research, maintaining active collaborations between the university's medical faculty and hospital research units to address emerging infectious disease challenges in immunocompromised hosts.

Antonino Di Caroمشاهده پروفایل

استاد

• Medical Microbiology
• Virology
• Infectious Disease Control
• +۳ مورد دیگر

Antonino Di Caro is a Full Professor at UniCamillus and Director of the Microbiology Laboratory and Infectious Diseases Biorepository at the National Institute for Infectious Diseases (INMI) in Italy. His expertise spans virology, bacterial infections, and biosafety. He holds specialty degrees in Medicine, Hygiene, Medical Microbiology, and Virology from the University of Rome. Educational Background: MD (1982), Hygiene & Public Health (1985), Hygiene & Hospital Management (1987), Medical Microbiology & Virology (1992). Roles: Member of INMI’s Institutional Biosafety Committee and Hospital Infection Control Committee. Research focuses on biodefense, emerging infections (e.g., Ebola, Monkeypox, SARS-CoV-2), biosafety, and diagnostic innovation. He leads/co-leads national and EU projects (e.g., EMERGE, EBOLA-MODRAD) and collaborates with WHO via the INMI WHO Collaborating Center. He advised during global health crises like the 2020 pandemic, earning the 'Cavaliere al Merito' honor. Publications emphasize viral outbreaks, diagnostic tools, and pathogen genomics. Recent work addresses SARS-CoV-2 variants, Monkeypox epidemiology, and tuberculosis drug resistance. Scientific Awards: Cavaliere al merito della Repubblica (2020). Grants/Projects: Principal Investigator in EU-funded programs on emerging infections.

• Clostridioides difficile Infection
• Irritable Bowel Syndrome (IBS)
• Ischemic Gastrointestinal Diseases
• +۳ مورد دیگر

Dr. Paul Feuerstadt is a Clinical Assistant Professor of Medicine at Yale School of Medicine, affiliated with the Division of Digestive Diseases. He holds clinical appointments at Yale-New Haven Hospital and its St. Raphael campus, as well as Milford Hospital. His expertise lies in gastrointestinal and hepatic diseases, with a focus on chronic diarrheal syndromes, Clostridioides difficile infection (C. diff), irritable bowel syndrome (IBS), and ischemic gut disorders. Dr. Feuerstadt earned his BA in Biology from the University of Pennsylvania (2000, Summa Cum Laude) and MD from Weill Cornell Medical College (2004). He completed residency in Internal Medicine and fellowship training in gastroenterology at New York Presbyterian Hospital/Weill Cornell and Montefiore Medical Center, respectively. His research emphasizes clinical outcomes, epidemiology, and treatment strategies for gastrointestinal diseases, particularly C. diff. Dr. Feuerstadt is an active educator, delivering lectures regionally and nationally, and mentors fellows in the Division of Digestive Diseases. He founded the educational resource Everythingcdifficile.com to address C. difficile infection for patients and providers. His publications span over 25 peer-reviewed articles in 2023-2024, focusing on microbiome therapeutics, clinical trial outcomes, and disparities in gastrointestinal disease management. Dr. Feuerstadt’s clinical practice prioritizes patient care, treating a broad spectrum of gastrointestinal and hepatic conditions. His work integrates translational research with clinical practice, aiming to improve patient outcomes through evidence-based approaches.

Mikhail Solovievمشاهده پروفایل

مدرس ارشد

• Nanoparticles in Medicine
• Stimuli-Responsive Proteins
• Molecular Biomarkers
• +۴ مورد دیگر

Dr. Mikhail Soloviev is a Senior Lecturer in the Department of Biological Sciences at Royal Holloway University of London, affiliated with the Centre for Biomedical Sciences. His research focuses on nanoparticles in medicine, functional protein engineering, molecular biomarkers for cancer detection, and analytical biochemistry. He has supervised 7 postgraduate students, including MSc and PhD candidates, and has contributed to over 90 publications. **Education & Research Interests**: Soloviev specializes in biomaterials, peptide engineering, and diagnostic technologies. His work aligns with UN Sustainable Development Goals related to health and innovation. He serves on editorial boards for journals like *Biomolecules* and *Current Bioinformatics*, and edited volumes on nanoparticles and peptidomics. **Grants & Projects**: He led projects on non-invasive cancer diagnostics (2018-2021) and breast cancer assays (2016-2020). Collaborations include institutions in the UK, China, and Germany. **Awards & Roles**: Editor for multiple journals, guest editor for special issues, and former Editor-in-Chief of *Journal of Nanobiotechnology*. His lab develops tools for early cancer detection and peptide-based therapies.

• Enzymology
• Biochemistry
• Antibiotic Development
• +۳ مورد دیگر

Dr. Ashleigh Paparella is a Lecturer (Teaching and Research) at the School of Medical Sciences, University of Sydney. She transitioned to this role after postdoctoral research at Albert Einstein College of Medicine (2017-2023), where she focused on enzyme transition state analysis and antibiotic development. Education : PhD in Biological Sciences (University of Adelaide, 2013-2017); BSc Honours in Biochemistry (University of Adelaide, 2012-2013); BSc in Biotechnology (University of Adelaide, 2009-2011) Her research explores the transition state structures of glycosyltransferases and their application in designing transition state analogues for novel antibiotics. Current projects target bacterial toxins like C. difficile TcdA/B and Staphylococcus aureus drug resistance mechanisms. Recent publications highlight her work on enzyme inhibition strategies, computational drug discovery, and chemical synthesis of potent antibacterial compounds. Collaborative studies span microbiology, structural biology, and pharmacology. Scientific Awards : Dennis Shields Award for Postdoctoral Research Excellence (2022), Postdoctoral Service Award (2019), both from Albert Einstein College of Medicine Dr. Paparella supervises research student Alfred HARTOJO and leads projects including the development of Two-Partner Secretion System inhibitors. She holds grants from the Centre for Drug Discovery Innovation (2024 EMCR Scheme, SABA Discovery Funding) and Faculty of Medicine and Health (2023 Start-up Scheme).

David van der Poortenمشاهده پروفایل

عضو هیئت علمی

• Hepatology
• Non-Alcoholic Fatty Liver Disease (NAFLD)
• Hepatitis C Virus (HCV)
• +۷ مورد دیگر

Dr. David van der Poorten is a Clinical Senior Lecturer at the University of Sydney's Westmead Clinical School, specializing in Gastroenterology and Hepatology. With over 15 years of clinical and research experience, his work bridges critical aspects of liver disease pathogenesis, microbiome interactions, and immunological responses in viral hepatitis. University of Sydney Westmead Clinical School Department of Gastroenterology and Hepatology His research portfolio demonstrates deep engagement with: Non-Alcoholic Fatty Liver Disease (NAFLD/NASH) mechanisms and metabolic interactions Immunological responses in chronic hepatitis B and C Microbiome studies in liver disease and Parkinson's disease Biomarker development for hepatocellular carcinoma Microbial translocation and phage dynamics Key article trends show: 2024 focus on colonoid models and Parkinson's microbiome interventions 2023 translational studies on C. difficile and regulatory frameworks 2022 global consensus building for MAFLD 2021-2020 advancements in NK cell immunology and fibrosis markers 2019-2018 clinical endoscopy and microbiome research 2017-2007 foundational work in fatty liver disease and Helicobacter pylori Dr. van der Poorten maintains active clinical practice at Sydney's leading hospitals while participating in: Multi-Disciplinary Meetings Advanced Therapeutic Endoscopy programs Clinical Trials Fibroscan implementation

• Diversity and Inclusion in Healthcare
• Medical Education
• Clinical Medicine
• +۳ مورد دیگر

Benjamin Mba, MBBS, MRCP (UK), CHCQM, FACP, is a Professor of Medicine (General Medicine) at Yale University’s Yale School of Medicine. He serves as Vice Chair of Diversity, Equity, and Inclusion (DEI) for the Department of Internal Medicine and GME Director for DEI at Yale New Haven Hospital (YNHH). Dr. Mba joined Yale in July 2023, bringing extensive experience in inclusive excellence advocacy, faculty development, and residency program leadership. He previously held roles as Associate Chair of Medicine for Faculty Development at Cook County Health and Professor at Rush Medical College. Education: MBBS from the University of Lagos, Nigeria; Internal Medicine residencies in the UK (MRCP-UK) and Cook County Hospital (Chief Resident). Research interests focus on DEI in healthcare, medical education, and clinical medicine. His work includes developing the Inclusion Activity Scale, an evaluation tool for DEI contributions in academic promotions. Key publications address health equity in education, disparities in cardiovascular outcomes, and trends in gastrointestinal and oncologic conditions. Awards include the Sir William Osler Award (four-time), Cook County’s Cooker Award (four-time), and the ACP Certificate of Appreciation for Mentoring. He is a sought-after speaker on DEI, clinical reasoning, and resident well-being. Led initiatives at Yale include the first departmental DEI climate survey, recruitment strategies for diverse faculty, and national studies on DEI impact metrics. Collaborates with YNHH on GME DEI policies and serves as an Associate Designated Institutional Official.

John Hawboldtمشاهده پروفایل

دانشیار

• Infectious Diseases
• Respirology
• Antimicrobial Stewardship
• +۹ مورد دیگر

Dr. John Hawboldt is an Associate Professor at Memorial University of Newfoundland (MUN), cross-appointed to the Faculty of Medicine (Respirology) and Eastern Health's Department of Pharmacy. He is a key faculty member in the School of Pharmacy, where he contributes to both academic and clinical training. His educational background includes a Doctor of Pharmacy from the University of Washington (2004), a Hospital Pharmacy Residency at Alberta Children’s Hospital (1993), and a degree from the University of Saskatchewan (1992). Dr. Hawboldt’s research and teaching focus on infectious diseases , respirology , antimicrobial stewardship , and the scholarship of teaching and learning . He is particularly interested in curriculum development, assessment, and improving patient outcomes through evidence-based pharmacy practice. His clinical work is centered on the Cystic Fibrosis Program at Eastern Health, serving both pediatric and adult patients. His recent publications highlight a strong trend in chronic respiratory disease management , especially COPD and cystic fibrosis, with a focus on mobile health interventions , medication adherence , and pharmacist-led care models . He also contributes significantly to infectious disease pharmacotherapy and antibiotic stewardship , with numerous reviews and clinical studies on pneumonia, C. difficile, and antimicrobial resistance. He serves on both Eastern Health and Provincial Antimicrobial Stewardship Committees, demonstrating leadership in improving healthcare delivery. His collaborative research involves multidisciplinary teams and includes pragmatic trials and mixed-methods studies. Dr. Hawboldt has supervised or collaborated on several projects related to pharmacy education and patient care, though formal advisees are not listed. He is actively involved in curriculum assessment and outcome achievement, contributing to the evolution of pharmacy education at MUN. His work is supported through institutional affiliations and clinical partnerships, with no specific grants mentioned. He is affiliated with research groups such as CHERP (Collaborative Health Evaluation and Research Program) and participates in Pharmacy Research Day and the Undergraduate Summer Research Program.